Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human (245) Apply Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Referrals Remove Referrals filter

Referral name

Referral status

European Commission final decision (226) Apply European Commission final decision filter CMDh final position (15) Apply CMDh final position filter Under evaluation (2) Apply Under evaluation filter

Referral safety status

Yes (66) Apply Yes filter

Referral type

Article 31 referrals Remove Article 31 referrals filter Article 29(4) referrals Remove Article 29(4) referrals filter Article 30 referrals (96) Apply Article 30 referrals filter Article 33 (45) Apply Article 33 filter Article 35 (45) Apply Article 35 filter Article 20 procedures (27) Apply Article 20 procedures filter Article 6(12) referrals (prior to January 2010) (21) Apply Article 6(12) referrals (prior to January 2010) filter Article 34 (20) Apply Article 34 filter Article 107 procedures (prior to July 2012) (15) Apply Article 107 procedures (prior to July 2012) filter Article 29 paediatrics (9) Apply Article 29 paediatrics filter Article 36 referrals (prior to July 2012) (9) Apply Article 36 referrals (prior to July 2012) filter Article 107i procedures (9) Apply Article 107i procedures filter Article 13 (6) Apply Article 13 filter Article 13 referrals (6) Apply Article 13 referrals filter Article 6(13) referrals (prior to January 2010) (5) Apply Article 6(13) referrals (prior to January 2010) filter Article 78 (5) Apply Article 78 filter Articles 39 and 40 (4) Apply Articles 39 and 40 filter Article 5(11) referrals (prior to January 2010) (2) Apply Article 5(11) referrals (prior to January 2010) filter Article 82 (2) Apply Article 82 filter

Referral reference number

Referral decision making model

PRAC-CHMP-EC (13) Apply PRAC-CHMP-EC filter PRAC-CMDh (29) Apply PRAC-CMDh filter

Referral authorisation model

Centrally and nationally authorised products (mixed) (13) Apply Centrally and nationally authorised products (mixed) filter Nationally authorised product(s) (53) Apply Nationally authorised product(s) filter

Referral PRAC recommendation

Revocation (3) Apply Revocation filter Risk minimisation measures (17) Apply Risk minimisation measures filter Suspension (3) Apply Suspension filter Variation (12) Apply Variation filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Date of opinion

From:

To:

Decision date

From:

To:

Medicine type

Additional monitoring (4) Apply Additional monitoring filter Exceptional circumstances (1) Apply Exceptional circumstances filter Generic (3) Apply Generic filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

245 results

Remove all filtersRemove all filters

Keyword Remove keyword

Referral type Article 31 referrals Remove Article 31 referrals filter Article 29(4) referrals Remove Article 29(4) referrals filter

Medicine Referrals Remove Referrals filter

Sort by

List item

Referral: Cilostazol-containing medicines

cilostazol, associated names: Pletal, Ekistol, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/03/2013, EC decision date: 24/06/2013, Last updated: 11/09/2013
List item

Referral: Oracea

doxycycline monohydrate, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 24/04/2008, EC decision date: 22/07/2008, Last updated: 21/08/2008
List item

Referral: Levact

bendamustine, associated names: Ribomustin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 07/07/2010, Last updated: 08/09/2011
List item

Referral: Adartrel

ropinirole, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 15/09/2005, EC decision date: 03/04/2006, Last updated: 21/04/2006
List item

Referral: Lisonorm

lisinopril, amlodipine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/07/2008, EC decision date: 12/11/2008, Last updated: 18/12/2008
List item

Referral: Cisapride

cisapride, Article 31 referrals
Status: European Commission final decision, opinion/position date: 13/12/2001, EC decision date: 30/05/2002, Last updated: 29/10/2002
List item

Referral: Sanohex

salbutamol, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/12/2008, EC decision date: 12/03/2009, Last updated: 30/03/2009
List item

Referral: Lansoprazol HEXAL 15 mg and 30 mg

Lansoprazole, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 23/06/2005, EC decision date: 15/09/2005, Last updated: 15/09/2005
List item

Referral: Vigabatrin

vigabatrin, Article 31 referrals
Status: European Commission final decision, opinion/position date: 20/05/1999, EC decision date: 05/10/1999, Last updated: 12/10/1998
List item

Referral: Mifepristone Linepharma

mifepristone, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 21/06/2012, EC decision date: 11/09/2012, Last updated: 03/01/2013
List item

Referral: Thiocolchicoside-containing medicines

thiocolchicoside, associated names: Muscoril and Coltramyl, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/11/2013, EC decision date: 17/01/2014, Last updated: 06/03/2014
List item

Referral: Fibrates

bezafibrate, ciprofibrate, fenofibrate, gemfibrozil, associated names: Bezalip, Lipanor, Lipanthyl, Lopid, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/10/2010, EC decision date: 28/02/2011, Last updated: 03/04/2013
List item

Referral: Chlormezanone

chlormezanone, Article 31 referrals
Status: European Commission final decision, opinion/position date: 23/01/1997, EC decision date: 27/08/1997, Last updated: 22/09/1997
List item

Referral: Anorectics

phentermine, amfepramome, clobenzorex, dexfenfluramine, fenbutrazate, fenfluramine, fenproporex, mazindol, mefenorex, norpseudoephedrine, phenmetrazine, phendimetrazine, propylhexedrine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 16/02/1996, EC decision date: 09/12/1996, Last updated: 10/12/1996
List item

Referral: Trimetazidine

trimetazidine, associated names: Vastarel, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/06/2012, EC decision date: 03/09/2012, Last updated: 17/10/2012
List item

Referral: Octegra

moxifloxacin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/03/2009, EC decision date: 02/10/2009, Last updated: 25/06/2009
List item

Referral: Ethirfin

morphine sulphate, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 23/09/2010, EC decision date: 20/12/2010, Last updated: 29/04/2011
List item

Referral: Myderison

tolperisone hydrochloride, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 22/10/2009, EC decision date: 06/08/2010, Last updated: 16/06/2011
List item

Referral: Glimepirida Parke-Davis

glimepiride, associated names: Glimepiride Pfizer, Glimepirid Pfizer, Glimepiride tablets 2 mg, Glimepiride tablets 3 mg, Glimepiride tablets 4 mg, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/07/2012, EC decision date: 19/11/2012, Last updated: 06/12/2012
List item

Referral: Amaryl

glimepiride, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 17/04/1996, EC decision date: 29/08/1996, Last updated: 03/08/1998
List item

Referral: Terpenic derivatives

camphor, cineole, niaouli, wild thyme, terpineol, terpine, citral, menthol, essential oils of pine needle, eucalyptus and turpentine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 17/11/2011, EC decision date: 20/01/2012, Last updated: 13/04/2012
List item

Referral: Pantoprazole Bluefish

pantoprazole, associated names: Pantecta, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/11/2009, EC decision date: 30/03/2010, Last updated: 09/03/2011
List item

Referral: Substances related to nicotinic acid

acipimox, associated names: Olbetam, Article 31 referrals
Status: European Commission final decision, opinion/position date: 18/12/2013, EC decision date: 20/02/2014, Last updated: 13/03/2014
List item

Referral: Diacerein-containing medicines for oral administration

diacerein, associated names: Zondar, Article 31 referrals
Status: European Commission final decision, EC decision date: 04/09/2014, Last updated: 19/09/2014
List item

Referral: Gadolinium-containing contrast agents

gadobenic acid, gadobutrol, gadodiamide, gadopentetic acid, gadoteric acid, gadoteridol, gadoversetamide, gadoxetic acid, associated names: Optimark, Article 31 referrals
Status: European Commission final decision, opinion/position date: 20/07/2017, EC decision date: 23/11/2017, Last updated: 04/12/2017

Load more

245 results

Referral: Cilostazol-containing medicines

Referral: Oracea

Referral: Levact

Referral: Adartrel

Referral: Lisonorm

Referral: Cisapride

Referral: Sanohex

Referral: Lansoprazol HEXAL 15 mg and 30 mg

Referral: Vigabatrin

Referral: Mifepristone Linepharma

Referral: Thiocolchicoside-containing medicines

Referral: Fibrates

Referral: Chlormezanone

Referral: Anorectics

Referral: Trimetazidine

Referral: Octegra

Referral: Ethirfin

Referral: Myderison

Referral: Glimepirida Parke-Davis

Referral: Amaryl

Referral: Terpenic derivatives

Referral: Pantoprazole Bluefish

Referral: Substances related to nicotinic acid

Referral: Diacerein-containing medicines for oral administration

Referral: Gadolinium-containing contrast agents